Skip to main content

Advertisement

Log in

Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Martin LE, Tanner RJ, Clark TJ, Cochrane GM . Absorption and metabolism of orally administered beclomethasone dipropionate. Clin Pharmacol Ther 1974; 15: 267–275.

    Article  CAS  Google Scholar 

  2. Tursi A, Giorgetti GM, Brandimarte G, Elisei W, Aiello F . Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. Med Sci Monit 2006; 12: PI29–PI32.

    PubMed  Google Scholar 

  3. Rizzello F, Gionchetti P, Galeazzi R, Novelli G, Valpiani D, D'Arienzo A et al. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study. Adv Ther 2001; 18: 261–271.

    Article  CAS  Google Scholar 

  4. Baehr PH, Levine DS, Bouvier ME, Hockenbery DM, Gooley TA, Stern JG et al. Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease. Transplantation 1995; 60: 1231–1238.

    Article  CAS  Google Scholar 

  5. McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial. Gastroenterology 1998; 115: 28–35.

    Article  CAS  Google Scholar 

  6. Iyer RV, Hahn T, Roy HN, Battiwalla M, Cooper M, Anderson B et al. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant 2005; 11: 587–592.

    Article  CAS  Google Scholar 

  7. Kishi Y, Kami M, Miyakoshi S, Kanda Y, Murashige N, Teshima T et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005; 80: 34–40.

    Article  Google Scholar 

  8. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586–3592.

    Article  Google Scholar 

  9. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 1464–1472.

    CAS  Google Scholar 

  10. Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005; 11: 429–436.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Kami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miura, Y., Narimatsu, H., Kami, M. et al. Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation. Bone Marrow Transplant 38, 577–579 (2006). https://doi.org/10.1038/sj.bmt.1705489

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705489

  • Springer Nature Limited

This article is cited by

Navigation